PAR-25-321 - Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 1
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications. | NOT-EB-23-002 | NIBIB , NCCIH , NCI , NHLBI , NIA , NIAID , NICHD , NIGMS | Apr 14, 2023 | May 17, 2026 | R01, R21, R35, R41/R42, R43/R44 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|